Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Transplantation Direct
|
April 4, 2022
Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant
Justin P Rosenheck, David J Ross, Mena Botros, et al.
JCO Precision Oncology
|
March 9, 2022
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
Pashtoon M Kasi, Gordon Fehringer, Hiroya Taniguchi, et al.
Human Molecular Genetics
|
October 21, 2015
Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions
David C Qian, Jinyoung Byun, Younghun Han, et al.
Nature
|
November 16, 2018
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
Shu Yi Shen, Rajat Singhania, Gordon Fehringer, et al.
International Journal of Cancer
|
January 26, 2017
Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study
Gordon Fehringer, Darren R Brenner, Zuo-Feng Zhang, et al.
Cancer Research
|
May 20, 2016
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations
Gordon Fehringer, Peter Kraft, Paul D Pharoah, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Transplantation Direct
|
April 4, 2022
Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant
Justin P Rosenheck, David J Ross, Mena Botros, et al.
JCO Precision Oncology
|
March 9, 2022
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
Pashtoon M Kasi, Gordon Fehringer, Hiroya Taniguchi, et al.
Human Molecular Genetics
|
October 21, 2015
Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions
David C Qian, Jinyoung Byun, Younghun Han, et al.
Nature
|
November 16, 2018
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
Shu Yi Shen, Rajat Singhania, Gordon Fehringer, et al.
International Journal of Cancer
|
January 26, 2017
Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study
Gordon Fehringer, Darren R Brenner, Zuo-Feng Zhang, et al.
Cancer Research
|
May 20, 2016
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations
Gordon Fehringer, Peter Kraft, Paul D Pharoah, et al.
Page
of 2